Simbarashe Takuva

Also affiliated with Fred Hutch Cancer Center, Perinatal HIV Research Unit, University of Pretoria

Immunology and MicrobiologyMedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition”.

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

New England Journal of Medicine(2021)10.1056/nejmoa2031738

N/A

6.2DataRank · unranked

547 citations

Peter B. Gilbert, Michal Juraska, David C. Montefiori, Lynn Morris, Shelly Karuna +40 more

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

The Lancet(2022)10.1016/s0140-6736(22)00007-1

N/A

4.4DataRank · unranked

85 citations

Nigel Garrett, Ameena Goga, Lara Fairall, Tarylee Reddy, Nonhlanhla Yende-Zuma +76 more

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00506-0

N/A

2.0DataRank · unranked

89 citations

An Vandebosch, Jerald Sadoff, Mathieu Le Gars, Carla Truyers, D. Lowson +95 more

Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial

The Lancet Infectious Diseases(2024)10.1016/s1473-3099(24)00358-x

N/A

1.3DataRank · unranked

40 citations

Kathryn Mngadi, Ludo Lavreys, Steven Nijs, Peter B. Gilbert, John Hural +60 more

Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein

Clinical Infectious Diseases(2020)10.1093/cid/ciz1239

N/A

1.2DataRank · unranked

35 citations

Craig Innes, Sarita Naidoo, Philipp Mann, Julia Hütter, Gita Ramjee +69 more

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial

PLoS Medicine(2022)10.1371/journal.pmed.1004024

N/A

0.961DataRank · unranked

21 citations

Azwidihwi Takalani, Ishen Seocharan, Nonhlanhla Yende‐Zuma, Tarylee Reddy, Imke Engelbrecht +23 more

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial

PLoS Medicine(2024)10.1371/journal.pmed.1004360

N/A

0.439DataRank · unranked

9 citations

Erica Andersen‐Nissen, Nicole Grunenberg, One Dintwe, Faatima Laher Omar, Jia Jin Kee +29 more

Allergic reactions to the Ad26.COV2.S vaccine in South Africa

Journal of Allergy and Clinical Immunology Global(2021)10.1016/j.jacig.2021.12.002

N/A

0.292DataRank · unranked

6 citations

Cascia Day, Simbarashe Takuva, Azwidihwi Takalani, Imke Engelbrecht, Nigel Garrett +8 more

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial

The Lancet HIV(2025)10.1016/s2352-3018(25)00012-8

N/A

0.292DataRank · unranked

6 citations

Carmen A. Paez, Chenchen Yu, Shelly Karuna, Theresa Gamble, Maurine D. Miner +32 more

A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings

UNC Libraries(2023)10.17615/42e2-fv64

N/A

0DataRank · unranked

0 citations

Simbarashe Takuva, Nyaradzo Mgodi, Srilatha Edupuganti, Gomez Lorenzo, M.M., Maurine D. Miner +24 more

Allergic reactions to the Ad26.COV2.S Vaccine in South Africa

(2024)10.22541/au.170668816.68864620/v1

N/A

0DataRank · unranked

0 citations

Cascia Day, Simbarashe Takuva, Azwidihwi Takalani, Imke Engelbrecht, Nigel Garrett +8 more